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Objective. Follicular helper T (Tfh) cells play a critical role in germinal center formation and B cell activation, both of which are hallmarks of primary Sj€ ogren's syndrome (SS). CCR9-expressing T helper cells have "Tfh-like" characteristics and their numbers are increased at mucosa-associated sites in several inflammatory conditions. Because the characteristics of these cells are unique and evaluation has been limited, this study was undertaken to investigate the local and systemic CCL25/CCR9 axis in patients with primary SS.
Methods. Levels of CCL25 protein and messenger RNA (mRNA) and CCR91 T helper cells were evaluated in the labial salivary glands (LSGs) of patients with primary SS and patients with sicca syndrome without a diagnosis of primary SS (non-SS sicca controls). CCL25 levels were assessed for correlation with parameters of inflammation and clinical features. Circulating CCR91 and CXCR51 T helper cells were compared on the basis of phenotypic and functional properties.
Results. CCL25 protein and mRNA levels were elevated in the LSGs of patients with primary SS as compared to non-SS sicca controls. Increased levels of CCL25 were associated with B cell hyperactivity, autoimmunity, and levels of interleukin-21 (IL-21) and soluble IL-7 receptor a-chain (IL-7Ra). Furthermore, the frequency of CCR9-expressing cells in the LSGs was increased and levels of circulating CCR91 T helper cells expressing programmed death 1 and inducible T cell costimulator were elevated in patients with primary SS. CCR91 T helper cells displayed higher expression of IL-7Ra and secreted higher levels of interferon-g, IL-17, IL-4, and IL-21 as compared to CXCR51 T helper cells, ex vivo and upon triggering with antigen or IL-7. Both CCR91 and CXCR51 T helper cells induced IgG production by B cells more potently than that induced in the cultures with CCR92CXCR52 T helper cells.
Conclusion. Enhanced expression of CCL25 in LSGs of patients with primary SS can facilitate attraction of CCR91 T helper cells, and these cells secrete high levels of proinflammatory cytokines when triggered with antigen or IL-7. The observed associations with B cell hyperactivity, autoimmunity, and markers of lymphoid neogenesis indicate that the CCL25/CCR9 axis plays a significant role in the immunopathology of primary SS, suggesting that this axis could represent a novel therapeutic target for the disease.
development (in ;10% of patients) (1, 2) . Both the presence of germinal centers (GCs) and a high number of lymphocytic infiltrates in the salivary glands are associated with lymphoma development (3, 4) . Follicular helper T (Tfh) cells are potent B cellstimulating cells and reside in GCs in the lymph nodes. Tfh cells are characterized by expression of Bcl-6, CXCR5, inducible T cell costimulator (ICOS), programmed death 1 (PD-1), and cytokines such as interleukin-21 (IL-21), IL-4, and CXCL13, which attracts CXCR51 Tfh cells and CXCR51 B cells (5, 6) . Tfh cells are elevated in the peripheral blood of patients with primary SS, and the frequency of Tfh cells correlates with autoantibody production, disease severity, and presence of aberrant memory B cell and plasma cell subsets. Expression of IL-21, IL-4, and CXCL13 as well as the numbers of Tfh cells are increased in the salivary glands of patients with primary SS (7) (8) (9) (10) .
McGuire et al recently described a novel CD41 T helper cell subset that has characteristics similar to those of Tfh cells, including the production of IL-21, expression of ICOS and Bcl-6, and expression of the chemokine receptor CCR9, but not CXCR5. These CCR91 T helper cells are therefore called "Tfh-like" cells (11) . Both in mice and in humans, CCR91 T helper cells are present in secondary lymphoid organs (12, 13) . In humans, CCR91 T helper cells produce high levels of interferon-g (IFNg) in addition to high levels of IL-17, IL-10, and IL-4. Moreover, these cells induce robust B cell responses (12, 14, 15) . They specifically migrate to mucosal sites in response to the chemokine CCL25 (also known as thymus-expressed chemokine, or TECK) (16, 17) . CCR91 T helper cells are important for the maintenance of mucosal immune homeostasis, but also may have a function in mucosal inflammation, potentially contributing to inflammatory bowel disease (IBD) and primary sclerosing cholangitis (18) (19) (20) . Increased numbers of CCR9-expressing cells have been found in the peripheral blood and inflamed intestinal tissue of patients with Crohn's disease, and elevated production of CCL25 has also been observed at sites of inflammation (21, 22) . Inhibition of CCR9 decreased intestinal inflammation in a mouse model of ileitis. In patients with Crohn's disease, inconsistent results with regard to the inhibition of CCR9 have been demonstrated, possibly because the pharmacokinetic properties of this smallmolecule therapy are poor (23) (24) (25) .
Recently, in NOD mice, CCR91 T cells were also shown to mediate immunopathologic processes in mucosa-associated tissue from accessory organs of the digestive tract, including the pancreas and salivary glands. The NOD mice spontaneously developed primary SS-like symptoms and exhibited infiltration of IL-21-expressing CCR91 T helper cells in the salivary glands (11) .
CCL25 messenger RNA (mRNA) is not detectable in healthy human salivary gland tissue, but is upregulated during oral inflammation (26) . Reduced methylation of the CCL25 gene is found in gingival tissue of patients with periodontitis (27) . In mice, CCL25 gene expression is up-regulated in the oral mucosa upon triggering with antigen and during wound healing (28, 29) .
Apart from demonstrating a pivotal role for CCR91 T helper cells in experimental SS-like disease, McGuire and colleagues found that CCR91 T helper cells are enriched in the circulation of patients with primary SS (11) , indicating that these cells might play a role in the disease. In the present study, we confirmed these findings and further characterized the role of CCR91 T helper cells in primary SS. We investigated the presence of CCR91 T helper cells and its specific ligand, CCL25, in the labial salivary glands (LSGs) of patients with primary SS. In addition, the phenotypic and functional properties of circulating CCR91 T helper cells were studied in comparison to CXCR51 T helper cells.
PATIENTS AND METHODS
Patients and controls. All patients with primary SS were classified according to the American-European Consensus Group (AECG) criteria for SS (30) . Patients with sicca syndrome who did not fulfill the AECG criteria for SS were defined as non-SS sicca disease controls. In both groups, autoantibody status and LSG biopsy samples were assessed. All patients, disease controls, and healthy volunteers were from the University Medical Center (UMC) Utrecht. The demographic and clinical characteristics of the patients and controls are shown in Table 1 . The UMC Utrecht ethics committee approved the study, and all participants gave written informed consent.
Analyses of CCL25 and CCR9 expression. CCL25 and CCR9 mRNA expression levels in the LSG biopsy tissue were assessed by quantitative reverse transcription-polymerase chain reaction; 18S was used as a housekeeping gene. The expression of mRNA was calculated using the 2 2DDCt method, with values normalized against the median value of the disease control group. To detect the secretion of CCL25 by LSG tissue, the LSGs were thoroughly rinsed directly after the biopsy procedure and incubated in 200 ml of saline for 1 hour at room temperature. The tissue supernatant was then frozen. Levels of CCL25 as well as IFNg, IL-17, IL-4, IL-21, IL-7, soluble IL-7 receptor a-chain (sIL-7Ra), and CXCL13 were measured using a Luminex multianalyte assay, as previously described (31) .
Immunohistochemical analysis was performed to detect CCR9 expression in the LSG samples. Frozen tissue sections were incubated with an anti-CCR9 monoclonal antibody; control incubations involved a mouse IgG2a isotype or omission of the first antibody. Antigen-antibody complexes 10 (29) 18 (69) 1 (11) 9 (90) 2 (22) 9 ( 10 (29) 19 (73) 2 (22) 7 (70) 1 (11) 7 ( 10 (38) 1 (11) 3 (30) 1 (11) 3 ( Isolation of cells. Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient centrifugation using Ficoll-Paque. Monocytes, CD191 B cells, and CD41 T cells were isolated from the PBMCs using an autoMACS system. To compare the functional characteristics of CCR91 T helper cells to those of CXCR51 T helper cells, 5-12 3 10 7 PBMCs from patients and healthy controls were obtained, and each cell subset was sorted using a BD FACSAria III flow cytometer. The cells were sorted for the expression of CD3, CD4, CXCR5, and CCR9, after which they were cultured.
Flow cytometric analysis. To characterize CCR91 T helper cells, 1 3 10 6 PBMCs from patients and healthy controls were stained for the expression of CD3, CD4, CD45RO, CXCR5, CCR9, CD127 (IL-7Ra), ICOS, and PD-1. Statistical analysis. Statistical analyses were performed in Prism version 6 and SPSS software. Student's t-test, a paired parametric t-test, Mann-Whitney U test, and nonparametric Wilcoxon's paired test were used as appropriate. For assessment of correlations with disease parameters, Pearson's correlation coefficient and Spearman's rho were used as appropriate. Differences and correlations were considered statistically significant at P values less than 0.05.
RESULTS
Correlation of increased levels of CCL25 in LSG tissue with B cell hyperactivity and factors associated with lymphoid neogenesis in primary SS. Levels of serum CCL25 were not significantly different in patients with primary SS (n 5 12) as compared to healthy controls (n 5 5) (median 2,748 pg/ml, interquartile range [IQR] 2,056-3,748 versus median 1,992 pg/ml, IQR 1,904-2,449; P 5 0.064). No significant correlations of the CCL25 serum levels with clinical parameters were found.
In the LSG biopsy samples, expression of CCL25 mRNA was significantly increased in patients with primary SS as compared to non-SS sicca controls ( Figure  1A) . In most individuals, expression of CCR9 mRNA in this tissue was not detectable or was very low.
Furthermore, CCL25 protein levels were significantly increased in the LSG biopsy supernatants from patients with primary SS as compared to non-SS sicca controls ( Figure 1B ). In addition, CCL25 protein levels were found to be elevated in anti-Ro/SSA-positive patients with primary SS as compared to those negative for anti-Ro/SSA ( Figure 1C) .
In LSG supernatants from all patients with sicca syndrome, the levels of CCL25 correlated with the lymphocytic focus score. In LSG supernatants from patients with primary SS, the CCL25 protein levels significantly correlated with an increased percentage of IgM-expressing and IgG-expressing plasma cells and increased serum IgG levels ( Figure 1D ). No significant correlations were found between the levels of CCL25 in LSGs and Schirmer's test results for eye dryness, the EULAR Sj€ ogren's Syndrome Disease Activity Index, or the EULAR Sj€ ogren's Syndrome Patient Reported Index (data not shown).
In view of the potential role of CCL25 in attracting CCR91 T helper cells, we assessed whether CCL25 protein expression in the tissue supernatants was associated with LSG expression of cytokines that are typically associated with Tfh cells and lymphoid neogenesis, including IL-21, CXCL13, IL-7, and sIL-7Ra (6, 32) . In addition, the major Th1-, Th2-, and Th17-defining cytokines IFNg, IL-4, and IL-17 were assessed. IFNg, IL-4, IL-17, and IL-7 were detectable in a minority of the LSG samples, which hampered the assessment of correlations with CCL25 protein expression (data not shown). Levels of IL-21 and sIL-7Ra, however, were significantly increased in patients with primary SS compared to non-SS sicca controls, and the levels of both cytokines correlated robustly with the levels of CCL25 ( Figure 1E ). Furthermore, CXCL13 levels were significantly increased in patients with primary SS as compared to non-SS sicca controls, but this did not correlate with the levels of CCL25 ( Figure 1E ).
Enhanced numbers of CCR9-expressing cells in primary SS LSGs. We confirmed the findings reported by McGuire et al (11) , observing that the frequency of CCR91CD41 T cells was increased in the peripheral blood of patients with primary SS as compared to healthy controls (mean 6 SD 3.0 6 1.3% versus 2.4 6 0.9%; P 5 0.041). In addition, we extended these findings by evaluating the numbers of CCR91 cells upon immunohistochemical staining of the LSG biopsy tissue. The numbers of CCR91 cells were increased in the LSGs of patients with primary SS as compared to non-SS sicca controls (Figures 2A and B) , and the presence of these cells largely colocalized with CD3 and CD4 ( Figure 2C ). In addition, 41.4 6 15.7% of the CCR91 cells expressed ICOS in the LSGs of patients with primary SS (n 5 4) ( Figure 2D ), thus confirming the presence of functional molecules associated with B cell activation.
CCR91 cells were found mostly near epithelial cells, in and around lymphocytic infiltrates. No significant correlations of CCR91 cell numbers with the lymphocytic focus score, percentage of IgG1IgM1 plasma cells, or serum IgG levels were found (data not shown).
High expression levels of IL-7Ra in circulating CCR91 T helper cells compared to CXCR51 T helper cells, and elevated proportions of circulating CCR91 T helper cells coexpressing ICOS and PD-1 in primary SS. Since the IL-7/IL-7Ra pathway plays an important role in the pathogenesis of primary SS (8, (33) (34) (35) (36) (37) and in (ectopic) GC formation, including that occurring in LSGs, expression of IL-7Ra on circulating CCR91 and CXCR51 T helper cells from patients with primary SS and healthy controls was studied (32, 38, 39) . CCR91 T helper cells showed a higher median fluorescence intensity of IL-7Ra expression as compared to CXCR51 T helper cells, both in patients with primary SS and in healthy controls (Figures 3A-C) . Figure 1 . Elevated expression of CCL25 in the labial salivary glands (LSGs) of patients with primary Sj€ ogren's syndrome (pSS) is associated with autoimmunity and B cell hyperactivity. A, CCL25 mRNA expression in LSG tissue was compared between patients with primary SS (n 5 9) and control sicca syndrome patients without a diagnosis of primary SS (nSS) (n 5 9). Relative expression was calculated with values normalized against the median value in the non-SS sicca controls; 18S was used as a housekeeping gene. FC 5 fold change. B and C, CCL25 protein concentrations (conc.) in LSG biopsy supernatants were compared between patients with primary SS (n 5 26) and non-SS sicca controls (n 5 34) (B) and between patients with primary SS who were positive for anti-Ro/SSA autoantibodies and those who were negative for anti-Ro/SSA (C). Symbols in A-C represent individual patients; horizontal lines indicate the median. D and E, CCL25 concentrations in LSG biopsy supernatants from all patients with sicca syndrome (primary SS and non-SS sicca), patients with primary SS, and non-SS sicca controls were assessed for correlations with the lymphocytic focus score (LFS), percentage of IgM-expressing and IgG-expressing plasma cells, and serum IgG levels (D) and for levels of interleukin-21 (IL-21), soluble IL-7 receptor a-chain (sIL-7Ra; a marker of the IL-7/IL-7Ra pathway), and CXCL13 (E). Spearman's correlation coefficients were used.
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BLOKLAND ET AL As CCR91 T helper cells share many features with Tfh cells, it was of particular interest to compare them to CXCR51 T helper cells. Expression of ICOS and PD-1, both of which are activation markers characteristically expressed on Tfh cells, was assessed (6) . Since the majority of PD-1 and ICOS in both cell subsets was expressed on the CD45RO1 effector memory cells and central memory cells, CD45RO1CCR91 and CD45RO1CXCR51 T helper cells from patients with primary SS were compared to those from healthy controls (40, 41) . Patients with primary SS displayed significantly increased numbers of ICOS and PD-1-coexpressing cells in the CCR91 T helper cell subset compared to that from healthy controls; this was not 
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BLOKLAND ET AL with primary SS and the healthy control group, no significant differences in circulating T helper cell subset polarization were found for either CCR91 T helper cells or CXCR51 T helper cells ( Figure 4B ). Naive, effector, effector memory, and central memory T helper cells were expected to produce different levels of cytokines. Therefore, the frequencies of these subsets within the CCR91 and CXCR51 T helper cell populations were assessed, showing that the CCR91 T helper cell subset contained a higher frequency of effector and effector memory cells, and the CXCR51 T helper cell subset contained a higher frequency of central memory cells (see Supplementary Figure 1 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.40182/abstract). These subsets were distinguished on the basis of the expression of CD45RO and CD27. 
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We subsequently assessed cytokine production in these cell subsets, and found that cytokine production differed between the subsets, as had also been observed in total CD41 T cells. Frequencies of IFNg1 cells were increased in all CCR91 T helper subsets, while the frequencies of IFNg1IL-171 cells and IL-101 cells were increased in the naive, effector memory, and central memory CCR91 T helper subsets, and the frequency of IL-211 cells was increased in the naive and central memory CCR91 T helper cell subset (see Robust production of IFNg, IL-4, IL-17, and IL-21 by antigen-and IL-7-triggered CCR91 T helper cells, compared to antigen-driven production of CXCL13 by CXCR51 T helper cells. In view of their crucial role in immunopathology, the function of CCR91 T helper cells from patients with primary SS and healthy controls were studied in cocultures with monocytes (43) . No significant differences in in vitro cytokine production were found between cocultures with primary SS patient cells and cocultures with healthy control cells. Therefore, the data on in vitro cytokine production were pooled together to compare the function of CCR91 and CXCR51 T helper cells. Upon restimulation, CCR91 T helper cells showed elevated production of IFNg, IL-17, and IL-4 as compared to CXCR51 T helper cells ( Figure 5A ). Production of IL-21 and CXCL13 under the same conditions was very low or undetectable (data not shown), and IL-10 production was not different between CCR91 and CXCR51 T helper cell cultures ( Figure 5A ).
To investigate T cell receptor-triggered T cell activation, which is expected to occur in the target organs when T helper cells enter the tissue, CCR91 and CXCR51 T helper cells were cultured in the presence of SEB antigen. Interestingly, CXCR51 T helper cells, when stimulated with SEB superantigen, produced levels of CXCL13 that were significantly higher than that produced by CCR91 T helper cells (P 5 0.043). In contrast, CCR91 T helper cells, in response to stimulation with SEB, produced higher levels of IFNg and IL-4 as compared to CXCR51 T helper cells (both P 5 0.043). In addition, CCR91 T helper cells produced higher levels of IL-17, IL-21, and IL-10 as compared to CXCR51 T helper cells, although this difference did not reach statistical significance ( Figure 5B ). IL-7Ra-mediated stimulation of the cells was also investigated, because it is known to play a role in the immunopathology of primary SS (8, (33) (34) (35) (36) (37) . A strong correlation of sIL-7Ra levels with CCL25 levels was observed in CCR91 T helper cells, and expression of IL-7Ra on CCR91 T helper cells was high. Stimulation with IL-7 induced CCR91 T helper cells to produce significantly higher amounts of IFNg, IL-21, and IL-4 as compared to that produced by CXCR51 T helper cells (P 5 0.018, P 5 0.018, and P 5 0.028, respectively). In addition, a trend toward increased production of IL-17 by CCR91 T helper cells was found (P 5 0.091). Production of CXCL13 was not significantly induced by IL-7, and production of IL-10 did not significantly differ between CCR91 T helper cells and CXCR51 T helper cells upon stimulation with IL-7 ( Figures 5A and B) .
Potent induction of IgG production by B cells in the presence of CCR91 and CXCR51 T helper cells as compared to CCR92CXCR52 T helper cells. Since both CCR91 and CXCR51 T helper cells have been described to potently induce the antibody responses of B cells, coculture of these cells with B cells was performed (6, 14) . Stimulation with IL-7 and SEB was performed to activate each subset of T helper cells. Both CCR91 and CXCR51 T helper cells induced B cell production of IgG, the levels of which were significantly increased as compared to that induced in the presence of CCR92CXCR52 T helper cells (P 5 0.025 and P 5 0.013, respectively) ( Figure 5C ).
DISCUSSION
The present study demonstrates, for the first time, increased levels of CCL25 and elevated numbers of CCR9-expressing cells in the salivary glands of patients with primary SS. Elevated CCL25 levels correlated with lymphocytic focus scores, B cell hyperactivity, autoimmunity (presence of anti-Ro/SSA autoantibodies), and expression of mediators potentially involved in lymphoid neogenesis (IL-21 and sIL-7Ra). Circulating CCR91 T helper cells from patients with primary SS displayed increased expression of ICOS and PD-1. In addition, we demonstrated that CCR91 T helper cells, as compared to CXCR51 T helper cells, had increased IL-7Ra expression, and increased proportions of CCR91 T helper cells, ex vivo and in response to stimulation with antigen and IL-7, produced higher levels of IFNg, IL-4, IL-17, and IL-21. The CXCR51 T helper cell subset, in turn, produced more CXCL13. Both CCR91 and CXCR51 T helper cells stimulated IgG production by B cells more potently than that by CCR92CXCR52 T helper cells. Taken together, these findings suggest a role for the CCL25/CCR9 axis in the pathogenesis of primary SS, in a manner that is distinct from that of CXCR51 T helper cells.
CCR9-expressing T helper cells both from patients with primary SS and from healthy controls were found to migrate in response to CCL25 (16, 26, 44) . CCL25 is found in the intestinal mucosa of patients with IBD as well as in healthy individuals, and is primarily produced by epithelial cells (21, 26) . However, CCL25 expression has not been detected in the LSGs of healthy individuals (26) . We show herein that expression of CCL25 mRNA and protein was increased in the salivary glands of patients with primary SS as compared to non-SS sicca controls. Moreover, consistent with the production of CCL25 by epithelial cells, we observed CCR91 cells mainly in the vicinity of epithelial cells. Although the trigger for CCL25 induction in the salivary glands of patients with primary SS is unknown, studies in cell lines and mice have demonstrated that viral and bacterial infections and tissue damage can up-regulate CCL25 expression in mucosal tissue (28, 29, (45) (46) (47) (48) .
We and others have shown that incubation of CCR91 T helper cells with CCL25 dramatically reduces CCR9 cell surface expression (44, 49) . This might explain the findings of a low frequency of CCR91 T helper cells at the site of inflammation without a significant correlation with the lymphocytic focus score. The lack of detection of CCR9 mRNA expression may be attributable to the characteristics of chemokine receptor expression. Since chemokine receptor genes are known to be low copy number genes and because the chemokine receptor proteins are recycled on the cell membrane, the expression of chemokine receptor mRNAs tends to be low and is often not directly correlated with the levels of protein present (50) . In support of a role for the CCL25/CCR9 axis in primary SS, we demonstrated significant correlations of CCL25 in LSG supernatants with the lymphocytic focus score, B cell hyperactivity, and autoimmunity in patients with primary SS. Consistent with this finding, increased expression of PD-1 and ICOS on CCR91 T helper cells in patients with primary SS was observed, indicating activation and potentially superior interaction with B cells.
Finally, in this study, we demonstrated the strong capability of CCR91 T helper cells to produce high levels of IFNg, IL-4, IL-10, IL-17, and IL-21 and to stimulate increased IgG production by B cells. Taken together, these findings suggest that these cells play a role in activation of B cells in primary SS. Expression of ICOS and PD-1 and production of the cytokines IL-4 and IL-21 by Tfh cells have been shown to play important roles in GC processes that induce long-term, highaffinity B cell responses (5, 6) . The Tfh-like role for CCR91 T helper cells is supported by the finding that they are potent inducers of antibody production (14) . A role for the CCL25/CCR9 T helper cell axis in autoimmunity and the immunopathology of primary SS is further supported by the increased frequencies of CCR91 T helper cells in the blood of patients with primary SS and by the capacity of CCR91 T helper cells to induce experimental sialadenitis, glandular disease, and autoimmunity (11) . Thus, despite their low numbers, increased numbers of CCR91 T cells in the salivary glands are shown to play a pivotal role in autoimmunity via the production of high levels of cytokines and the capacity to stimulate B cells (14) .
Corresponding to the findings of previous studies that focused on CCR91 T helper cells in healthy controls, ex vivo studies in patients with primary SS showed that CCR91 T helper cells produced high levels of the Th1 and Th17 cytokines IFNg and IL-17 as compared to CXCR51 T helper cells (14, 15) . In addition, we demonstrated that CCR91 T helper cells producing IL-10 were enriched in patients with primary SS (14) . Herein we demonstrate, for the first time, that human CCR91 T helper cells encompass enriched proportions of IL-21-producing cells, as well as the proinflammatory Th17.1 cell subset that produces both IFNg and IL-17.
In vitro, CCR91 T helper cells were superior producers of IFNg, IL-4, IL-17, and IL-21 as compared to CXCR51 T helper cells, depending on the stimulus. Upon triggering of the T cell receptor, elevated production of IFNg and IL-4 by CCR91 T helper cells was found, but CXCR51 T helper cells were superior producers of CXCL13. Interestingly, IL-7-induced activation caused strong up-regulation of all of the cytokines measured, except for CXCL13, and CCR91 T helper cells produced significantly elevated levels of IFNg, IL-4, and IL-21 compared to CXCR51 T helper cells. In addition, we demonstrated a strong correlation of CCL25 levels with sIL-7Ra levels, which recently was shown to strongly enhance IL-7-induced immune activation in vivo (51) . Considering these findings and the pivotal role of the IL-7/IL-7Ra pathway in lymphoid neogenesis in salivary glands, IL-7-driven activation of CCR91 T helper cells may play a pivotal role in this process (32) .
Our results showed that CCL25 levels did not correlate with CXCL13 levels in the LSGs, and that CCR91 T helper cells did not produce high levels of CXCL13 as compared to CXCR51 T helper cells. In addition, CCR91 T helper cells were much more potent cytokine producers in response to IL-7 than CXCR51 T helper cells. These findings, in combination with the Tfh-like characteristics of CCR91 T helper cells, indicate a distinct role for the IL-7/IL-7R-associated CCL25/ CCR9 axis as compared to the CXCL13/CXCR5 axis in B 2048 BLOKLAND ET AL cell activation and lymphocyte infiltration, including GClike structure formation, in patients with primary SS. Both in the ex vivo and in vitro experiments, we demonstrated equally potent cytokine production by CCR91 T helper cells from patients with primary SS and healthy controls. In view of the increased expression of PD-1 and ICOS on CCR91 T helper cells from patients with primary SS, this finding is still unexplained. Currently, we are investigating coexpression of other chemokine receptors on CCR91 T helper cells to support the hypothesis that subsets of CCR91 T helper cells migrate in response to coexpressed chemokine receptors, which would thus explain the lack of increased circulating cytokine-secreting cells.
In conclusion, elevated expression of CCL25 and increased numbers of CCR91 cells in the LSGs of patients with primary SS correlate with clinical features, including lymphocytic infiltration in the LSGs, B cell hyperactivity, and autoimmunity. Peripheral blood CCR91 T helper cells from patients with primary SS displayed increased expression of ICOS and PD-1. When compared to CXCR51 T helper cells, the CCR91 T helper cells were found to be IL-7Ra high and produced elevated levels of IFNg, IL-4, IL-17, and IL-21, especially upon IL-7R-mediated stimulation. Considering the pivotal role of CCR91 T cells in an experimental SS-like disease model, our findings suggest an important role for the CCL25/CCR9 axis in the immunopathology of primary SS, thus representing a novel therapeutic target in this disease.
